These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12535859)

  • 1. Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model.
    Takahara A; Sugiyama A; Satoh Y; Yoneyama M; Hashimoto K
    Eur J Pharmacol; 2003 Jan; 460(1):51-7. PubMed ID: 12535859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations.
    Sugiyama A; Yatomi Y; Takahara A; Satoh Y; Hashimoto K
    Jpn J Pharmacol; 2002 Mar; 88(3):359-61. PubMed ID: 11949893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs.
    Iizuka K; Shimizu Y; Tsukagoshi H; Yoshii A; Harada T; Dobashi K; Murozono T; Nakazawa T; Mori M
    Eur J Pharmacol; 2000 Oct; 406(2):273-9. PubMed ID: 11020491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutional rho-kinase regulates atrioventricular nodal conduction and ventricular repolarization of the canine heart.
    Sugiyama A; Takahara A; Yatomi Y; Satoh Y; Nakamura Y; Hashimoto K
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):930-3. PubMed ID: 12775972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
    Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
    Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632.
    Köksel O; Yildirim C; Tiftik RN; Kubat H; Tamer L; Cinel L; Kaplan MB; Değirmenci U; Ozdülger A; Büyükafşar K
    Eur J Pharmacol; 2005 Mar; 510(1-2):135-42. PubMed ID: 15740734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats.
    Teraishi K; Kurata H; Nakajima A; Takaoka M; Matsumura Y
    Eur J Pharmacol; 2004 Nov; 505(1-3):205-11. PubMed ID: 15556154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
    Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
    Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.
    Rees RW; Foxwell NA; Ralph DJ; Kell PD; Moncada S; Cellek S
    J Urol; 2003 Dec; 170(6 Pt 1):2517-22. PubMed ID: 14634463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Rho-kinase in human gallbladder contractions.
    Büyükafşar K; Akça T; Nalan Tiftik R; Sahan-Firat S; Aydin S
    Eur J Pharmacol; 2006 Jul; 540(1-3):162-7. PubMed ID: 16730697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes.
    Goto D; Fujii S; Kaneko T; Furumoto T; Sugawara T; Tarikuz Zaman AK; Imagawa S; Dong J; Nakai Y; Mishima T; Sobel BE; Kitabatake A
    Biochem Pharmacol; 2003 Jun; 65(11):1907-14. PubMed ID: 12781343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Y-27632, a Rho/Rho kinase inhibitor, on leukotriene D(4)- and histamine-induced airflow obstruction and airway microvascular leakage in guinea pigs in vivo.
    Tokuyama K; Nishimura H; Iizuka K; Kato M; Arakawa H; Saga R; Mochizuki H; Morikawa A
    Pharmacology; 2002 Apr; 64(4):189-95. PubMed ID: 11893899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of agonist-induced positive inotropy by a selective Rho-associated kinase inhibitor, Y-27632.
    Nishimaru K; Tanaka Y; Tanaka H; Shigenobu K
    J Pharmacol Sci; 2003 Aug; 92(4):424-7. PubMed ID: 12939528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Horinaka S; Mita S; Nakano S; Honda T; Yoshida K; Kobayashi T; Matsuoka H
    Cardiovasc Res; 2002 Sep; 55(4):757-67. PubMed ID: 12176125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rho-kinase inhibitor, Y-27632, reduces cholinergic contraction but not neurotransmitter release.
    Fernandes L; D'Aprile A; Self G; McGuire M; Sew T; Henry P; Goldie R
    Eur J Pharmacol; 2006 Nov; 550(1-3):155-61. PubMed ID: 17010334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection.
    Mills TM; Chitaley K; Lewis RW; Webb RC
    Eur J Pharmacol; 2002 Mar; 439(1-3):173-4. PubMed ID: 11937108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice.
    Büyükafşar K; Un I
    Eur J Pharmacol; 2003 Jul; 472(3):235-8. PubMed ID: 12871759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes.
    Kawaguchi A; Ohmori M; Harada K; Tsuruoka S; Sugimoto K; Fujimura A
    Eur J Pharmacol; 2000 Sep; 403(3):203-8. PubMed ID: 10973620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats.
    Büyükafşar K; Arikan O; Ark M; Kubat H; Ozveren E
    Eur J Pharmacol; 2004 Sep; 498(1-3):211-7. PubMed ID: 15363997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.